CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 258 filers reported holding CRISPR THERAPEUTICS AG in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,021 | -58.2% | 375 | -48.3% | 0.00% | – |
| Q2 2023 | $40,702 | +24.1% | 725 | 0.0% | 0.00% | – |
| Q1 2023 | $32,792 | +11.3% | 725 | 0.0% | 0.00% | – |
| Q4 2022 | $29,471 | -37.3% | 725 | 0.0% | 0.00% | – |
| Q3 2022 | $47,000 | +6.8% | 725 | 0.0% | 0.00% | – |
| Q2 2022 | $44,000 | +15.8% | 725 | +20.8% | 0.00% | – |
| Q1 2022 | $38,000 | -69.6% | 600 | -63.6% | 0.00% | – |
| Q4 2021 | $125,000 | -3.1% | 1,650 | +43.5% | 0.00% | -100.0% |
| Q3 2021 | $129,000 | +14.2% | 1,150 | +64.3% | 0.00% | – |
| Q2 2021 | $113,000 | +32.9% | 700 | 0.0% | 0.00% | – |
| Q1 2021 | $85,000 | -20.6% | 700 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $107,000 | +81.4% | 700 | 0.0% | 0.00% | – |
| Q3 2020 | $59,000 | +15.7% | 700 | 0.0% | 0.00% | – |
| Q2 2020 | $51,000 | +168.4% | 700 | +55.6% | 0.00% | – |
| Q1 2020 | $19,000 | +216.7% | 450 | +350.0% | 0.00% | – |
| Q4 2019 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -20.0% | 100 | +25.0% | 0.00% | – |
| Q2 2018 | $5,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |